負責領導醫療事務戰略並在藥物安全監視、真實世界臨床證據研究/臨床試驗和 MSL infield excellence擁有廣泛的職能能力。在醫療和商業領域獨特的雙邊職業發展，她的專業經驗在上市數個突破性治療得到了認可，其明確果斷及高度的市場敏感度,熱情而富有遠見的領導力帶領團隊在企業和亞太區獲得了各種獎項。
在加入艾伯維之前，Annie 是賽諾菲台灣和香港的副醫學處長，在BMS、拜耳和諾華在醫學和商業領域擁有 10 多年的豐富經驗。 專注於免疫學、腫瘤學、血液腫瘤學、眼科和神經科學領域的新產品上市。獲台灣大學生化所博士學位，專攻酶動力學及抗菌藥物發展；繼續在耶魯大學醫學院藥理所從事抗癌在動物及臨床試驗的博士後研究並發表數篇國際論文。
Shawn Jeng is the Medical Affairs Director of ONO Pharma Taiwan with a focus on developing a highly accountable and knowledge-driven medical team. He brings his decade of experience and leadership to his current role where he is dedicated to mentoring, inspiring and motivating field medicals how to maximize science for value in patients.
目前為台灣賽諾菲疫苗部醫學經理，負責多項疫苗部台灣分公司真實世界數據生成的計畫。畢業於陽明大學醫學系，加入製藥業前為多年臨床醫師與核子醫學專科醫師，專長為核子醫學影像判讀與核醫藥物治療。從住院醫師時代至今，已有近十年臨床研究經驗，對於臨床研究與學術發表過程十分熟稔，已發表多篇同儕審查論文於高影響力期刊，並曾獲多項研究獎項。同時，也曾多次在核醫與疫苗領域擔任高影響力期刊的審查者。目前就讀於約翰霍普金斯大學公衛碩士學程。
David have been in the industry for over 13 years. After leaving academia, David started his medical affairs career as a MSL and has progressed through various with roles and responsibilities from country, region, and global. He has lived in Asia, Australasia, and Europe.
An active outdoor person, David enjoys playing rugby and is recently learning paragliding.
David is passionate about bringing new technologies and opportunities into Taiwan to strengthen the local ecosystem.
I am an experienced medical manager of Sanofi Vaccines Taiwan and has been leading several local real-world evidence generation projects. Before joining pharmaceutical industry, I worked as a clinical physician for 7 years, specializing and board-certified in nuclear medicine. I am quite familiar with research and publication processes, and has around ten years of clinical research experiences with multiple published peer-reviewed articles and several research awards. In addition, I also have experiences as reviewer in prestigious magazines in both nuclear medicine and vaccine fields. Currently enrolled in Johns Hopkins University part-time MPH program.
Tony Yeh 在 小野藥廠工作了 5 年。小野藥廠是一家持續開發新療法來對抗疾病的製藥公司。作為醫療事務團隊的資深學術經理的一員，Tony 協助團隊獲得免疫療法新的適應症, 並積極生成真實世界數據, 以滿足臨床上的需求。面對 COVID-19流行，建立了數位平台的轉型。
Tony Yeh has worked in ONO Pharma for going on 5 years. He is the Senior Medical Manager of ONO, a pharma sustained develops new therapies to against disease. As part of Medical Affairs team, Tony has worked hard to launch new indication of immunotherapy and generate local data to fulfil the unmet need. In the face of the COVID-19 pandemic, the digital transformation is established and incorporated into the medical plan.
